Vir Biotechnology to Participate in TD Cowen 45th Annual Health Care Conference
Vir Biotechnology (Nasdaq: VIR) has announced its executive team's upcoming participation in the TD Cowen 45th Annual Health Care Conference. The company will engage in a fireside chat scheduled for Tuesday, March 4 at 8:50 a.m. PT / 11:50 a.m. ET in Boston, Massachusetts.
The event will be accessible through a live webcast available in the Investors section of Vir Biotechnology's website under Events & Presentations. The recording will remain archived for 30 days following the presentation.
Vir Biotechnology (Nasdaq: VIR) ha annunciato la partecipazione imminente del suo team esecutivo alla 45ª Conferenza Annuale sulla Salute di TD Cowen. L'azienda prenderà parte a una conversazione informale programmata per martedì 4 marzo alle 8:50 PT / 11:50 ET a Boston, Massachusetts.
L'evento sarà accessibile tramite un webcast dal vivo disponibile nella sezione Investitori del sito web di Vir Biotechnology sotto Eventi e Presentazioni. La registrazione rimarrà archiviata per 30 giorni dopo la presentazione.
Vir Biotechnology (Nasdaq: VIR) ha anunciado la próxima participación de su equipo ejecutivo en la 45ª Conferencia Anual de Salud de TD Cowen. La compañía participará en una charla informal programada para el martes 4 de marzo a las 8:50 a.m. PT / 11:50 a.m. ET en Boston, Massachusetts.
El evento será accesible a través de una transmisión en vivo disponible en la sección de Inversores del sitio web de Vir Biotechnology bajo Eventos y Presentaciones. La grabación permanecerá archivada durante 30 días después de la presentación.
Vir Biotechnology (Nasdaq: VIR)가 TD Cowen 제45회 연례 건강 관리 컨퍼런스에 임원 팀의 참여를 발표했습니다. 이 회사는 매사추세츠주 보스턴에서 3월 4일 화요일 오전 8시 50분 PT / 오전 11시 50분 ET에 예정된 화상 대화에 참여할 예정입니다.
이 이벤트는 Vir Biotechnology 웹사이트의 투자자 섹션에서 이벤트 및 발표 아래에 있는 라이브 웹캐스트를 통해 접근할 수 있습니다. 발표 후 30일 동안 녹화본이 보관됩니다.
Vir Biotechnology (Nasdaq: VIR) a annoncé la participation prochaine de son équipe dirigeante à la 45e Conférence Annuelle sur la Santé de TD Cowen. L'entreprise participera à une discussion informelle prévue pour le mardi 4 mars à 8h50 PT / 11h50 ET à Boston, Massachusetts.
L'événement sera accessible via un webinaire en direct disponible dans la section Investisseurs du site web de Vir Biotechnology sous Événements & Présentations. L'enregistrement restera archivé pendant 30 jours après la présentation.
Vir Biotechnology (Nasdaq: VIR) hat die bevorstehende Teilnahme seines Führungsteams an der 45. jährlichen Gesundheitskonferenz von TD Cowen bekannt gegeben. Das Unternehmen wird an einem Fireside-Chat teilnehmen, der für Dienstag, den 4. März um 8:50 Uhr PT / 11:50 Uhr ET in Boston, Massachusetts, geplant ist.
Die Veranstaltung wird über einen Live-Webcast zugänglich sein, der im Investorenbereich der Website von Vir Biotechnology unter Veranstaltungen & Präsentationen verfügbar ist. Die Aufzeichnung bleibt 30 Tage nach der Präsentation archiviert.
- None.
- None.
A live webcast of the fireside chat will be made available under Events & Presentations in the Investors section of the Vir Biotechnology website and will be archived for 30 days.
About Vir Biotechnology
Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes infectious disease programs for chronic hepatitis delta and chronic hepatitis B infections and multiple dual-masked T-cell engagers across validated targets in solid tumor indications. Vir Biotechnology also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies. Vir Biotechnology routinely posts information that may be important to investors on its website.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250219968347/en/
Media
Arran Attridge
Senior Vice President, Corporate Communications
aattridge@vir.bio
Investors
Richard Lepke
Senior Director, Investor Relations
rlepke@vir.bio
Source: Vir Biotechnology, Inc.
FAQ
When is Vir Biotechnology (VIR) presenting at the TD Cowen Health Care Conference?
How can investors watch VIR's presentation at the TD Cowen Conference?
How long will VIR's TD Cowen Conference presentation be available for viewing?
What type of presentation will VIR give at the TD Cowen Health Care Conference?
